Role of MIC-1 in Gastric Cancer: Constructing a Eukaryotic Expression Vector for Future Research

Role of MIC-1 in Gastric Cancer: Constructing a Eukaryotic Expression Vector for Future Research

Gastric cancer remains a major health concern, with a 5-year survival rate below 40%. Effective treatments are limited, emphasizing the need for understanding its development and exploring potential therapeutic targets. This study focuses on Macrophage inhibitory cytokine-1 (MIC-1), a protein with a complex and dual role in gastric cancer.

MIC-1, a member of the transforming growth factor-β superfamily, was first identified by Bootcov MR and isolated from U937 macrophages. While MIC-1 exhibits anticancer properties in early gastric cancer by inducing apoptosis and inhibiting proliferation, its role shifts in advanced stages. Changes in the tumor microenvironment lead MIC-1 to promote cancer progression by:

• Inhibiting beta-catenin gene expression* Increasing protease activity* Enhancing stromal collagen degradation* Decreasing cell adhesion

These changes ultimately contribute to cancer cell detachment and metastasis, making MIC-1 a critical target for further investigation.

This study aimed to construct a eukaryotic expression vector, pEGFP-N1-MIC1, for the MIC-1 gene. This vector provides a crucial tool for future research exploring the complex mechanisms of MIC-1 in gastric cancer development. The pEGFP-N1-MIC1 vector will enable researchers to:

• Study the specific functions of MIC-1 in different stages of gastric cancer* Investigate the impact of MIC-1 on tumor microenvironment and metastasis* Evaluate the potential of targeting MIC-1 for therapeutic interventions

The successful construction of this vector lays a strong foundation for future research endeavors aimed at combating this devastating disease.